These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35365744)

  • 21. Association of Metformin Use During Hospitalization and Mortality in Critically Ill Adults With Type 2 Diabetes Mellitus and Sepsis.
    Gómez H; Del Rio-Pertuz G; Priyanka P; Manrique-Caballero CL; Chang CH; Wang S; Liu Q; Zuckerbraun BS; Murugan R; Angus DC; Kellum JA
    Crit Care Med; 2022 Jun; 50(6):935-944. PubMed ID: 35120041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin Use Is Associated with Fewer Complications in Patients with Type-2 Diabetes Undergoing Total Knee Arthroplasty: A Propensity Score-Matched Analysis.
    Wilson JM; Farley KX; Broida SE; Bradbury TL; Guild GN
    J Bone Joint Surg Am; 2021 Apr; 103(7):601-608. PubMed ID: 33787554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
    Do JY; Kim SW; Park JW; Cho KH; Kang SH
    Diabetes Metab; 2021 Jul; 47(4):101208. PubMed ID: 33160030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study.
    Chen TH; Li YR; Chen SW; Lin YS; Sun CC; Chen DY; Mao CT; Wu M; Chang CH; Chu PH; Wu VC
    Cardiovasc Diabetol; 2020 Nov; 19(1):189. PubMed ID: 33167990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin Use in Diabetes Prior to Hospitalization: Effects on Mortality in Covid-19.
    Li J; Wei Q; Li WX; McCowen KC; Xiong W; Liu J; Jiang W; Marin T; Thomas RL; He M; Gongol B; Hepokoski M; Yuan JX; Shyy JY; Xiong N; Malhotra A
    Endocr Pract; 2020 Oct; 26(10):1166-1172. PubMed ID: 33471718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
    Chen Y; Lv X; Lin S; Arshad M; Dai M
    Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin Use Is Associated With Lower Mortality in Veterans With Diabetes Hospitalized With Pneumonia.
    Mohammed T; Bowe M; Plant A; Perez M; Alvarez CA; Mortensen EM
    Clin Infect Dis; 2023 Apr; 76(7):1237-1244. PubMed ID: 36575139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus.
    Yang W; Sun X; Zhang J; Zhang K
    Diabetes Res Clin Pract; 2021 Aug; 178():108977. PubMed ID: 34302912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can metformin change the prognosis of pancreatic cancer? Retrospective study for pancreatic cancer patients with pre-existing diabetes mellitus type 2.
    Lee SH; Yoon SH; Lee HS; Chung MJ; Park JY; Park SW; Song SY; Chung JB; Bang S
    Dig Liver Dis; 2016 Apr; 48(4):435-40. PubMed ID: 26775128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
    Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study.
    Strongman H; D'Oca K; Langerman H; Das R
    Diabetes Obes Metab; 2015 Jun; 17(6):573-580. PubMed ID: 25735201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.
    Reitz KM; Marroquin OC; Zenati MS; Kennedy J; Korytkowski M; Tzeng E; Koscum S; Newhouse D; Garcia RM; Vates J; Billiar TR; Zuckerbraun BS; Simmons RL; Shapiro S; Seymour CW; Angus DC; Rosengart MR; Neal MD
    JAMA Surg; 2020 Jun; 155(6):e200416. PubMed ID: 32267474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of adverse in-hospital outcome and recovery in patients with diabetes mellitus and COVID-19 pneumonia in Iraq.
    Nafakhi H; Alareedh M; Al-Buthabhak K; Shaghee F; Nafakhi A; Kasim S
    Diabetes Metab Syndr; 2021; 15(1):33-38. PubMed ID: 33296788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature.
    Singh AK; Singh R; Saboo B; Misra A
    Diabetes Metab Syndr; 2021; 15(1):159-167. PubMed ID: 33352455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.
    Mima Y; Kuwashiro T; Yasaka M; Tsurusaki Y; Nakamura A; Wakugawa Y; Okada Y
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):436-46. PubMed ID: 26725260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes.
    Wang J; Cooper JM; Gokhale K; Acosta-Mena D; Dhalla S; Byne N; Chandan JS; Anand A; Okoth K; Subramanian A; Bangash MN; Jackson T; Zemedikun D; Taverner T; Hanif W; Ghosh S; Narendran P; Toulis KA; Tahrani AA; Surenthirakumaran R; Adderley NJ; Haroon S; Khunti K; Sainsbury C; Thomas GN; Nirantharakumar K
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1255-1268. PubMed ID: 33560344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
    Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
    Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Death and Heart Failure among Patients with Type 2 Diabetes Treated by Metformin and Nonmetformin Monotherapy: A Real-World Study.
    He S; Qian X; Chen Y; Shen X; Zhang B; Chen X; Xu X; Li G
    J Diabetes Res; 2021; 2021():5534387. PubMed ID: 34222493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.